Literature DB >> 350265

A double blind comparison of guanethidine-and-adrenaline drops with 1% adrenaline alone in chronic simple glaucoma.

K B Mills, A E Ridgway.   

Abstract

We present the results of a double-blind trial comparing the efficacy of a single dose combination of guanethidine 3% and adrenaline 0.5% with that of adrenaline 1% alone in reducing the intraocular pressure of eyes suffering from chronic open-angle glaucoma. The mean fall in ocular tension with the combined therapy was 10.67 mmHg, and with adrenaline 1% 6.31 mmHg, 24 hours after the commencement of phasing. The combined drop produced satisfactory control of ocular tension in all cases. These results indicate that a combined drop of guanethidine 3% and adrenaline 0.5% is a promising topical therapy for the control of chronic open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350265      PMCID: PMC1043221          DOI: 10.1136/bjo.62.5.320

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

1.  Topical epinephrine therapy of open-angel glaucoma.

Authors:  B BECKER; T H PETTIT; A J GAY
Journal:  Arch Ophthalmol       Date:  1961-08

2.  Effect of 2% levo-rotary epinephrine on the intraocular pressure of the glaucomatous eye.

Authors:  L L GARNER; W W JOHNSTONE; E J BALLINTINE; M E CARROLL
Journal:  AMA Arch Ophthalmol       Date:  1959-08

3.  Epinephrine and acetazolamide in the therapy of the chronic glaucomas.

Authors:  B BECKER; A P LEY
Journal:  Am J Ophthalmol       Date:  1958-05       Impact factor: 5.258

4.  Recent advances and future prospects in the medical treatment of ocular hypertension.

Authors:  R WEEKERS; E PRIJOT; J GUSTIN
Journal:  Br J Ophthalmol       Date:  1954-12       Impact factor: 4.638

5.  Guanethidine (Ismelin) in ophthalmology. I. Observations in rabbits.

Authors:  J A OOSTERHUIS
Journal:  Arch Ophthalmol       Date:  1962-05

6.  Guanethidine and adrenaline used in combination in chronic simple glaucoma.

Authors:  J A Roth
Journal:  Br J Ophthalmol       Date:  1973-07       Impact factor: 4.638

7.  Drug therapy of glaucoma.

Authors:  G D Paterson; G Paterson
Journal:  Br J Ophthalmol       Date:  1972-03       Impact factor: 4.638

8.  Guanethidine and glaucoma.

Authors:  J Gloster
Journal:  Trans Ophthalmol Soc U K       Date:  1974-07

9.  The mechanism of action of guanethidine on aqueous humor dynamics.

Authors:  E D Hendley; K E Eakins
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

10.  Comparison of bretylium and guanethidine: tolerance, and effects on adrenergic nerve function and responses to sympathomimetic amines.

Authors:  A L BOURA; A F GREEN
Journal:  Br J Pharmacol Chemother       Date:  1962-08
View more
  3 in total

1.  Control of glaucoma by reduced dosage guanethidine-adrenaline formulation.

Authors:  D E Jones; D A Norton; D J Davies
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

2.  A long term study of low concentration guanethidine and adrenaline therapy in glaucoma.

Authors:  S Nagasubramanian; J Gloster; D Poinoosawmy; R Watkins
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

3.  Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study).

Authors:  U Urner-Bloch; J E Aeschlimann; B P Gloor
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.